Insights Center
ML Strategies Viewpoints
Search
Showing 65 - 72 of 543 results
ML Strategies Health Care Preview - Week of March 25, 2019
March 26, 2019
Device Modernization Series: In Vitro Clinical Tests
March 7, 2019|Blog
What to Expect at FDA Following Commissioner Gottlieb's Departure
March 6, 2019|Blog
ML Strategies Health Care Preview - Week of March 4, 2019
March 4, 2019|Blog
What Does the Future Hold for Drug Pricing?
February 28, 2019|Blog
Device Modernization Series: FDA’s Proposed De Novo Regulation
February 28, 2019|Blog
ML Strategies Health Care Preview - Week of February 25th
February 26, 2019|Blog
Device Modernization Series: FDA’s Changes to the 510(k) Program
February 21, 2019|Blog
News & Press Releases
Hahn Signals COVID-19 Could Affect User Fee Goals, Device Talks Put Off
April 20, 2020 | Inside Health Policy
An article published by Inside Health Policy quoted remarks made by Senior Director of ML Strategies Aaron Josephson during a recent Mintz and ML Strategies webinar focused on the U.S. Food and Drug Administration (FDA)’s response to the COVID-19 pandemic.
Au Pairs Caught Between Work and a Pandemic
April 2, 2020 | The New York Times
In an article published by The New York Times, Senior Vice President, Strategic Communications of ML Strategies Nancy J. Sterling was quoted on behalf of client Au Pair in America, a federally approved organization that helps match au pairs and host families, on resources and support provided to both families and au pairs during the coronavirus pandemic.